Evoke Pharma Inc
NASDAQ:EVOK

Watchlist Manager
Evoke Pharma Inc Logo
Evoke Pharma Inc
NASDAQ:EVOK
Watchlist
Price: 22.2 USD -1.11% Market Closed
Market Cap: 18.9m USD

Relative Value

EVOK doesn't have a meaningful market cap.

The Relative Value of one EVOK stock under the Base Case scenario is hidden USD. Compared to the current market price of 22.2 USD, Evoke Pharma Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EVOK Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
57
vs Industry
85
Median 3Y
0.8
Median 5Y
4.5
Industry
2.7
Forward
1.2
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-2.1
Industry
21.6
Forward
-5.7
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-2.6
Industry
16.9
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-2.6
Industry
22.9
vs History
47
vs Industry
71
Median 3Y
1.3
Median 5Y
3
Industry
2.3
vs History
57
vs Industry
92
Median 3Y
0.2
Median 5Y
4
Industry
3
Forward
0.8
vs History
47
vs Industry
88
Median 3Y
0.2
Median 5Y
1.4
Industry
5.6
vs History
vs Industry
53
Median 3Y
-0.2
Median 5Y
-1.8
Industry
13.4
vs History
vs Industry
50
Median 3Y
-0.2
Median 5Y
-1.8
Industry
16.7
Forward
-2.5
vs History
vs Industry
54
Median 3Y
-0.2
Median 5Y
-2.1
Industry
16.1
vs History
vs Industry
41
Median 3Y
-0.2
Median 5Y
-2.1
Industry
18.9
vs History
52
vs Industry
82
Median 3Y
1.7
Median 5Y
22.5
Industry
2

Multiples Across Competitors

EVOK Competitors Multiples
Evoke Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Evoke Pharma Inc
NASDAQ:EVOK
18.9m USD 1.3 -3.6 -2.4 -2.4
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 109 159.5
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.4 10.2 12.1
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
US
Evoke Pharma Inc
NASDAQ:EVOK
Average P/E: 24.9
Negative Multiple: -3.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Evoke Pharma Inc
NASDAQ:EVOK
Average EV/EBITDA: 440
Negative Multiple: -2.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
109
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Evoke Pharma Inc
NASDAQ:EVOK
Average EV/EBIT: 1 883.6
Negative Multiple: -2.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.5
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5